probenecid has been researched along with Amyotonia Congenita in 2 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curzon, G | 1 |
| Schaub, RG | 1 |
| Meyers, KM | 1 |
2 other studies available for probenecid and Amyotonia Congenita
| Article | Year |
|---|---|
CSF homovanillic acid: an index of dopaminergic activity.
Topics: Antiparkinson Agents; Brain; Dopamine; Hepatic Encephalopathy; Homovanillic Acid; Humans; Huntington | 1975 |
Evidence for a small functional pool of serotonin in neurohumoral transmission.
Topics: Animals; Dog Diseases; Dogs; Fenclonine; Hydroxyindoleacetic Acid; Neuromuscular Diseases; Neurotran | 1975 |